Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Reynes

Showing results (101-110 of 200) with videos related to

Pageof 20
Sort By:
AIDS (London, England)|June 5, 2007
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adultsDirk Schürmann, Gerd Fätkenheuer, Jacques Reynes, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 8, 2016
Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based TherapyTruong Tam Nguyen, Reihani Niloofar, Pierre-Alain Rubbo, et al.
Mycoses|October 8, 2014
Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patientsThierry K Ngouana, Donika Krasteva, Pascal Drakulovski, et al.
AIDS (London, England)|September 15, 2004
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20Anne-Geneviève Marcelin, Jacques Reynes, Sabine Yerly, et al.
Critical Care Medicine|March 28, 2009
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006)Olivier Leroy, Jean-Pierre Gangneux, Philippe Montravers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2012
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 studyLise Cuzin, Selma Trabelsi, Pierre Delobel, et al.
Ebiomedicine|November 28, 2020
Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infectionSophie Novelli, Camille Lécuroux, Cécile Goujard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapyMarie-Laure Chaix, Remonie Seng, Pierre Frange, et al.
Journal of Virology|September 16, 2004
Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individualsJean-Michel Fondere, Gael Petitjean, Marie-France Huguet, et al.
Retrovirology|March 11, 2009
Suppression of HIV-1 replication by microRNA effectorsChristine Chable-Bessia, Oussama Meziane, Daniel Latreille, et al.
Pageof 20

Showing results (101-110 of 200) with videos related to

Sort By:
Pageof 20
AIDS (London, England)|June 5, 2007
Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adultsDirk Schürmann, Gerd Fätkenheuer, Jacques Reynes, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 8, 2016
Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based TherapyTruong Tam Nguyen, Reihani Niloofar, Pierre-Alain Rubbo, et al.
Mycoses|October 8, 2014
Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patientsThierry K Ngouana, Donika Krasteva, Pascal Drakulovski, et al.
AIDS (London, England)|September 15, 2004
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20Anne-Geneviève Marcelin, Jacques Reynes, Sabine Yerly, et al.
Critical Care Medicine|March 28, 2009
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006)Olivier Leroy, Jean-Pierre Gangneux, Philippe Montravers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2012
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 studyLise Cuzin, Selma Trabelsi, Pierre Delobel, et al.
Ebiomedicine|November 28, 2020
Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infectionSophie Novelli, Camille Lécuroux, Cécile Goujard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapyMarie-Laure Chaix, Remonie Seng, Pierre Frange, et al.
Journal of Virology|September 16, 2004
Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individualsJean-Michel Fondere, Gael Petitjean, Marie-France Huguet, et al.
Retrovirology|March 11, 2009
Suppression of HIV-1 replication by microRNA effectorsChristine Chable-Bessia, Oussama Meziane, Daniel Latreille, et al.
Pageof 20